IP-10/MIG receptor designated CXCR3, nucleic acids, and methods of use therefor
AssigneeTheodor-Kocher Institute
InventorsMarcel Loetscher, Bernhard Moser
Life of this patent
Estimating the term…
Abstract
The invention relates to isolated and/or recombinant nucleic acids encoding a mammalian (e.g., human) CXCR3 protein and variants thereof, including antisense nucleic acid, recombinant nucleic acid constructs, such as plasmids or retroviral vectors, comprising a nucleic acid which encodes a protein of the present invention or variant thereof, and to host cells comprising a nucleic acid or construct, useful in the production of recombinant proteins. The invention also relates to a method for producing a mammalian (e.g., human) CXCR3 protein.
Claims44
An isolated nucleic acid encoding a human CXC Chemokine Receptor 3 (CXCR3) protein, wherein said CXCR3 protein binds one or more chemokines selected from the group consisting of human IP-10 and human Mig, and wherein said nucleic acid hybridizes to a second nucleic acid selected from the group consisting of the complement of SEQ ID NO:1 and the complement of the open reading frame of SEQ ID NO:1 under high stringency wash conditions of 2×SSC, 0.1% SDS at room temperature for ten minutes followed by two washes in 1×SSC, 0.1% SDS at 65° C. for thirty minutes and a final wash in 0.5×SSC, 0.1% SDS at 65° C. for ten minutes.
An isolated nucleic acid encoding a protein comprising the amino acid sequence of FIG. 2 (SEQ ID NO:2).
An isolated nucleic acid encoding a human CXC Chemokine Receptor 3 (CXCR3) protein, wherein the amino acid sequence of said CXCR3 protein is a sequence encoded by the nucleic acid of FIG. 1 (SEQ ID NO:1).
A recombinant nucleic acid encoding a fusion protein comprising a human CXC Chemokine Receptor 3 (CXCR3) protein, wherein said CXCR3 protein binds one or more chemokines selected from the group consisting of human IP-10 and human Mig, and wherein said CXCR3 protein is encoded by a nucleic acid which hybridizes to a second nucleic acid selected from the group consisting of the complement of SEQ ID NO:1 and the complement of the open reading frame of SEQ ID NO:1 under high stringency wash conditions of 2×SSC, 0.1% SDS at room temperature for ten minutes followed by two washes in 1×SSC, 0.1% SDS at 65° C. for thirty minutes and a final wash in 0.5×SSC, 0.1% SDS at 65° C. for ten minutes.
A recombinant nucleic acid encoding a fusion protein comprising a human CXC Chemokine Receptor 3 (CXCR3) protein, wherein the amino acid sequence of said CXCR3 protein is a sequence encoded by the nucleic acid of FIG. 1 (SEQ ID NO:1).
A recombinant nucleic acid encoding a fusion protein comprising a human CXC Chemokine Receptor 3 (CXCR3) protein, wherein the amino acid sequence of said CXCR3 protein consists of the amino acid sequence of FIG. 2 (SEQ ID NO:2).
A recombinant nucleic acid construct comprising a nucleic acid encoding a human CXC Chemokine Receptor 3 (CXCR3) protein, wherein said CXCR3 protein binds one or more chemokines selected from the group consisting of human IP-10 and human Mig, and wherein said nucleic acid encoding a human CXCR3 protein hybridizes to a second nucleic acid selected from the group consisting of the complement of SEQ ID NO:1 and the complement of the open reading frame of SEQ ID NO:1 under high stringency wash conditions of 2×SSC, 0.1% SDS at room temperature for ten minutes followed by two washes in 1×SSC, 0.1% SDS at 65° C. for thirty minutes and a final wash in 0.5×SSC, 0.1% SDS at 65° C. for ten minutes.
A recombinant nucleic acid construct comprising a nucleic acid encoding a human CXC Chemokine Receptor 3 (CXCR3) protein, wherein the amino acid sequence of said CXCR3 protein is a sequence encoded by the nucleic acid of FIG. 1 (SEQ ID NO:1).
A recombinant nucleic acid construct comprising a nucleic acid encoding a protein comprising the amino acid sequence of FIG. 2 (SEQ ID NO:2).
A host cell comprising a recombinant nucleic acid encoding a human CXC Chemokine Receptor 3 (CXCR3) protein, wherein said CXCR3 protein binds one or more chemokines selected from the group consisting of human IP-10 and human Mig, wherein said nucleic acid encoding a human CXCR3 protein hybridizes to a second nucleic acid selected from the group consisting of the complement of SEQ ID NO:1 and the complement of the open reading frame of SEQ ID NO:1 under high stringency wash conditions of 2×SSC, 0.1% SDS at room temperature for ten minutes followed by two washes in 1×SSC, 0.1% SDS at 65° C. for thirty minutes and a final wash in 0.5×SSC, 0.1% SDS at 65° C. for ten minutes, and wherein said host cell is not in a transgenic animal.
A host cell comprising a recombinant nucleic acid encoding a human CXC Chemokine Receptor 3 (CXCR3) protein, wherein the amino acid sequence of said CXCR3 protein is a sequence encoded by the nucleic acid of FIG. 1 (SEQ ID NO:1), and wherein said host cell is not in a transgenic animal.
A host cell comprising a recombinant nucleic acid encoding a protein comprising the amino acid sequence of FIG. 2 (SEQ ID NO:2), wherein said host cell is not in a transgenic animal.
A method for producing a human CXC Chemokine Receptor 3 (CXCR3) protein, wherein said protein binds one or more chemokines selected from the group consisting of human IP-10 and human Mig, the method comprising:
- (a) introducing into a host cell a nucleic acid encoding said human CXCR3 protein, wherein said nucleic acid hybridizes to a second nucleic acid selected from the group consisting of the complement of SEQ ID NO:1 and the complement of the open reading frame of SEQ ID NO:1 under high stringency wash conditions of 2×SSC, 0.1% SDS at room temperature for ten minutes followed by two washes in 1×SSC, 0.1% SDS at 65° C. for thirty minutes and a final wash in 0.5×SSC, 0.1% SDS at 65° C. for ten minutes, whereby a recombinant host cell is produced having said nucleic acid operably linked to an expression control sequence;
- and
- (b) maintaining the recombinant host cell produced in step (a) under conditions whereby the nucleic acid is expressed.
An isolated nucleic acid having a sequence that is the complement of a second nucleic acid which encodes a human CXC Chemokine Receptor 3 (CXCR3) protein, wherein said protein binds one or more chemokines selected from the group consisting of human IP-10 and human Mig, and wherein said second nucleic acid hybridizes to a third nucleic acid selected from the group consisting of the complement of SEQ ID NO:1 and the complement of the open reading frame of SEQ ID NO:1 under high stringency wash conditions of 2×SSC, 0.1% SDS at room temperature for ten minutes followed by two washes in 1×SSC, 0.1% SDS at 65° C. for thirty minutes and a final wash in 0.5×SSC, 0.1% SDS at 65° C. for ten minutes.
An isolated nucleic acid that is the complement of SEQ ID NO:1 or the complement of a portion of SEQ ID NO:1 comprising the open reading frame.
An isolated nucleic acid that is the complement of a second nucleic acid which encodes a protein comprising the amino acid sequence of SEQ ID NO:2.
An isolated nucleic acid that is the complement of a second nucleic acid which encodes a human CXC Chemokine Receptor 3 (CXCR3) protein, wherein the amino acid sequence of said CXCR3 protein is a sequence encoded by the nucleic acid of FIG. 1 (SEQ ID NO:1).
A recombinant nucleic acid having a sequence that is the complement of a second nucleic acid which encodes a human CXC Chemokine Receptor 3 (CXCR3) protein, wherein said protein binds one or more chemokines selected from the group consisting of human IP-10 and human Mig, and wherein said second nucleic acid hybridizes to a third nucleic acid selected from the group consisting of the complement of SEQ ID NO:1 and the complement of the open reading frame of SEQ ID NO:1 under high stringency wash conditions of 2×SSC, 0.1% SDS at room temperature for ten minutes followed by two washes in 1×SSC, 0.1% SDS at 65° C. for thirty minutes and a final wash in 0.5×SSC, 0.1% SDS at 65° C. for ten minutes.
An isolated nucleic acid encoding a human CXC Chemokine Receptor 3 (CXCR3) protein, wherein said nucleic acid comprises SEQ ID NO:1 or a portion of SEQ ID NO:1 comprising the open reading frame.
Dependencies are inferred from the claim text.